Strategic Collaboration in Biotechnology
Conigen Bioscience, a pioneering entity in the field of innovative protein engineering, has recently partnered with North Star Scientific, a specialized sales agency in the life sciences and biotechnology sector. This collaboration aims to broaden access to advanced, biotechnological tools crucial for drug discovery and development.
Advancements in Protein Engineering
With a commitment to transforming the landscape of therapeutic antibody development, Conigen is known for producing bioactive recombinant proteins that perfectly replicate dimeric-specific epitopes. These advancements represent a significant leap in the field, as they address the critical shortage of functional tool molecules necessary for successful drug development.
The Vision Behind Conigen
Founded by Jean Qiu, PhD, and Shixia Wang, PhD, DVM, Conigen focuses on improving scientific reproducibility. Their recombinant homodimer and heterodimer proteins boast over tenfold increased potency in receptor and ligand interactions compared to traditional monomer proteins, thereby expanding the range of potential therapeutic solutions, including bi-specific antibodies, antibody-drug conjugates, and CAR-T therapies.
Strengthening Market Presence
Jean Qiu, the CEO of Conigen Bioscience, expressed enthusiasm about the partnership with North Star Scientific. This collaboration merges Conigen's pioneering approach to protein engineering with North Star’s expertise in sales and business development, enhancing their market reach to support researchers in their innovative pursuits.
North Star Scientific's Role
Jeff Storelee, Managing Partner of North Star Scientific, emphasized the alignment of their mission with Conigen’s vision. Through strategic growth initiatives and lead generation, North Star aims to enhance the distribution of Conigen’s innovative protein tools, ultimately helping researchers address significant challenges in life sciences.
Commitment to Quality and Innovation
Both companies share a deep commitment to providing quality products and dedicated support to researchers. By combining their skill sets, they aim to empower scientists to tackle complex challenges confidently, facilitating advancements in biotechnology and healthcare.
About Conigen Bioscience
Conigen Bioscience is at the forefront of engineering conformational proteins to drive significant innovation in immunotherapy and drug discovery. By leveraging advanced protein engineering techniques, the company delivers cutting-edge solutions that assist scientists in overcoming complex research challenges.
About North Star Scientific, Inc.
North Star Scientific acts as a vital partner in the life sciences sector, enhancing market exposure for biotech and pharmaceutical manufacturers. Their focus on quality and strategic growth positions them well to support businesses seeking to expand their market footprint across North America.
Contact Information
For inquiries or additional information about this partnership and the services offered by Conigen Bioscience and North Star Scientific, you can reach out to Polly Mitchell at 508-388-4188.
Frequently Asked Questions
What is the purpose of the Conigen and North Star partnership?
The partnership aims to broaden access to advanced biotechnological tools essential for drug discovery and therapeutic development.
What innovative technologies does Conigen specialize in?
Conigen specializes in bioactive recombinant proteins that replicate dimeric-specific epitopes, improving the efficacy of therapeutic candidates.
Who are the founders of Conigen Bioscience?
Conigen was co-founded by Jean Qiu, PhD, and Shixia Wang, PhD, DVM, who both possess extensive expertise in protein engineering.
How does North Star Scientific contribute to the partnership?
North Star Scientific provides sales and business development support, helping Conigen expand its market presence and reach researchers.
What is the common goal of both companies?
Both companies aim to tackle complex challenges in the life sciences by delivering high-quality products and robust support to scientists and researchers.
